CYAN Stock Overview
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cyanotech Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.30 |
| 52 Week High | US$1.16 |
| 52 Week Low | US$0.12 |
| Beta | 0.28 |
| 1 Month Change | 3.41% |
| 3 Month Change | -66.24% |
| 1 Year Change | -69.09% |
| 3 Year Change | -90.73% |
| 5 Year Change | -90.75% |
| Change since IPO | -69.95% |
Recent News & Updates
Recent updates
Cyanotech Corporation (NASDAQ:CYAN) Not Doing Enough For Some Investors As Its Shares Slump 39%
Feb 15
Is Cyanotech (NASDAQ:CYAN) Using Debt Sensibly?
Feb 09Is Cyanotech (NASDAQ:CYAN) Weighed On By Its Debt Load?
Oct 05There's Been No Shortage Of Growth Recently For Cyanotech's (NASDAQ:CYAN) Returns On Capital
Sep 30Here's Why Cyanotech (NASDAQ:CYAN) Can Manage Its Debt Responsibly
Aug 14Cyanotech GAAP EPS of -$0.08, revenue of $6.72M
Aug 10Cyanotech (NASDAQ:CYAN) Might Have The Makings Of A Multi-Bagger
Jun 08Is Cyanotech (NASDAQ:CYAN) A Risky Investment?
May 12The ESG Future Of Food Protein Production: Cyanotech
Mar 19Cyanotech (NASDAQ:CYAN) Is Doing The Right Things To Multiply Its Share Price
Mar 04We Think Cyanotech (NASDAQ:CYAN) Can Stay On Top Of Its Debt
Jan 11Cyanotech (NASDAQ:CYAN) Is Experiencing Growth In Returns On Capital
Nov 30Cyanotech (NASDAQ:CYAN) Is Carrying A Fair Bit Of Debt
Jun 08Cyanotech's (NASDAQ:CYAN) Promising Earnings May Rest On Soft Foundations
Feb 23These 4 Measures Indicate That Cyanotech (NASDAQ:CYAN) Is Using Debt Reasonably Well
Feb 08
Returns On Capital Tell Us A Lot About Cyanotech (NASDAQ:CYAN)
Jan 04Cyanotech Corporation's (NASDAQ:CYAN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Nov 30Cyanotech reports Q2 results
Nov 12Shareholder Returns
| CYAN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -8.9% | 5.4% | 1.2% |
| 1Y | -69.1% | -25.4% | 24.7% |
Return vs Industry: CYAN underperformed the US Personal Products industry which returned -32.6% over the past year.
Return vs Market: CYAN underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| CYAN volatility | |
|---|---|
| CYAN Average Weekly Movement | 31.5% |
| Personal Products Industry Average Movement | 8.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CYAN's share price has been volatile over the past 3 months.
Volatility Over Time: CYAN's weekly volatility has increased from 17% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 86 | Matt Custer | www.cyanotech.com |
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company’s products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services.
Cyanotech Corporation Fundamentals Summary
| CYAN fundamental statistics | |
|---|---|
| Market cap | US$2.09m |
| Earnings (TTM) | -US$4.62m |
| Revenue (TTM) | US$22.49m |
0.1x
P/S Ratio-0.5x
P/E RatioIs CYAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CYAN income statement (TTM) | |
|---|---|
| Revenue | US$22.49m |
| Cost of Revenue | US$15.78m |
| Gross Profit | US$6.72m |
| Other Expenses | US$11.33m |
| Earnings | -US$4.62m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 29.86% |
| Net Profit Margin | -20.52% |
| Debt/Equity Ratio | 49.2% |
How did CYAN perform over the long term?
See historical performance and comparison